NRx Sale Purchase Of Stock from 2010 to 2024

NRXPW Stock  USD 0.05  0  2.30%   
NRx Pharmaceuticals Sale Purchase Of Stock yearly trend continues to be fairly stable with very little volatility. Sale Purchase Of Stock is likely to outpace its year average in 2024. During the period from 2010 to 2024, NRx Pharmaceuticals Sale Purchase Of Stock regression line of quarterly data had r-squared of  0.70 and coefficient of variation of  219.03. View All Fundamentals
 
Sale Purchase Of Stock  
First Reported
2010-12-31
Previous Quarter
-23.7 M
Current Value
-22.5 M
Quarterly Volatility
51.6 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check NRx Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among NRx Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 4.8 K, Interest Expense of 114 K or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. NRx financial statements analysis is a perfect complement when working with NRx Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of NRx Pharmaceuticals Correlation against competitors.
For more information on how to buy NRx Stock please use our How to Invest in NRx Pharmaceuticals guide.

Latest NRx Pharmaceuticals' Sale Purchase Of Stock Growth Pattern

Below is the plot of the Sale Purchase Of Stock of NRx Pharmaceuticals over the last few years. It is NRx Pharmaceuticals' Sale Purchase Of Stock historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in NRx Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Sale Purchase Of Stock10 Years Trend
Slightly volatile
   Sale Purchase Of Stock   
       Timeline  

NRx Sale Purchase Of Stock Regression Statistics

Arithmetic Mean23,580,277
Coefficient Of Variation219.03
Mean Deviation49,541,145
Median70,025,100
Standard Deviation51,648,066
Sample Variance2667.5T
Range110.8M
R-Value(0.83)
Mean Square Error873.2T
R-Squared0.70
Significance0.0001
Slope(9,635,155)
Total Sum of Squares37345.3T

NRx Sale Purchase Of Stock History

2024-22.5 M
2023-23.7 M
2020-26.3 M
2018-40.7 M

About NRx Pharmaceuticals Financial Statements

NRx Pharmaceuticals investors use historical fundamental indicators, such as NRx Pharmaceuticals' Sale Purchase Of Stock, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in NRx Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Sale Purchase Of Stock-23.7 M-22.5 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for NRx Stock Analysis

When running NRx Pharmaceuticals' price analysis, check to measure NRx Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NRx Pharmaceuticals is operating at the current time. Most of NRx Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of NRx Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NRx Pharmaceuticals' price. Additionally, you may evaluate how the addition of NRx Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.